Table 2.

Spearman correlations between serum FGF19 levels and various physiological and clinical indicators.

	All patients		Women		Men
	r	P-value	r	P-value	r	P-value
Age (years)	0.063	0.439	−0.091	0.436	0.178	0.122
BMI (kg/m2)	−0.095	0.243	0.093	0.428	−0.251*	0.022
Body weight (kg)	−0.181*	0.026	−0.201	0.080	−0.037	0.752
WHR	0.037	0.650	0.248*	0.032	0.052	0.652
FBG (mmol/L)	−0.044	0.594	0.089	0.447	−0.186	0.106
2hPG (mmol/L)	−0.092	0.304	−0.020	0.875	−0.190	0.136
HbA1c (%)	−0.102	0.211	−0.085	0.468	−0.063	0.587
HDL-c (mmol/L)	0.093	0.257	0.013	0.912	0.065	0.558
LDL-c (mmol/L)	−0.020	0.803	0.002	0.985	−0.109	0.325
ALT (U/L)	0.005	0.956	0.184	0.113	−0.140	0.224
TBIL (μmol/L)	−0.148	0.070	−0.101	0.395	−0.133	0.247
BUN (mmol/L)	0.089	0.279	0.006	0.960	0.183	0.112
Cr (μmol/L)	−0.133	0.105	−0.228	0.050	0.043	0.710
TG (mmol/L)	−0.087	0.287	0.086	0.461	−0.206	0.072
TC (mmol/L)	−0.027	0.742	0.091	0.437	−0.131	0.258
24hUALB (mg/24 h)	0.008	0.924	0.040	0.734	0.004	0.975
FINS (μU/mL)	−0.189*	0.020	−0.004	0.970	−0.388**	0.001
HOMA-IR	−0.163*	0.045	0.007	0.949	−0.353**	0.002
AIP	−0.106	0.197	0.065	0.583	−0.206	0.073
SBP (mmHg)	−0.099	0.226	−0.106	0.365	−0.113	0.328
DBP (mmHg)	−0.130	0.109	−0.055	0.640	−0.182	0.113

BMI, body mass index; WHR, waist/hip ratio; FBG, fasting blood glucose; 2hPG, 2-h post-prandial blood glucose; HbA1c, hemoglobin A1c; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; ALT, alanine transaminase; TBIL, total bilirubin; BUN, blood urea nitrogen; Cr, creatinine; TC, total cholesterol; TG, triglycerides; 24hUALB, 24-h urine microalbumin; FINS, fasting insulin; HOMA-IR, homeostasis model assessment of insulin resistance; AIP, plasma atherosclerosis index; SBP, systolic blood pressure; DBP, diastolic blood pressure.